Internal Medicine Practice Questions — USMLE Step 2 CK — Page 62

Question 1221Question →

Based on the clinical indications and current guidelines, which of the following is the most appropriate initial or add-on antihypertensive medication class for each patient described below?

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct pairings align the patient's comorbidities with the specific benefits of each antihypertensive class: the patient with nephrolithiasis matches with a thiazide-type diuretic; the diabetic patient with albuminuria matches with an angiotensin-converting enzyme inhibitor; the patient with stable angina matches with a cardioselective beta-blocker; and the Black patient with uncomplicated hypertension matches with a dihydropyridine calcium channel blocker.

Each patient's clinical scenario contains compelling indications for a specific antihypertensive class based on current joint guidelines. Thiazides prevent calcium stones; ACE inhibitors protect diabetic kidneys; beta-blockers relieve angina; and calcium channel blockers are first-line for Black patients with uncomplicated hypertension.

Step-by-Step Solution

1

Evaluate the patient with recurrent calcium oxalate stones and osteopenia.

Identify that this patient benefits from decreased urinary calcium excretion.

Thiazide diuretics uniquely decrease urinary calcium, preventing stones and aiding bone health.

2

Assess the diabetic patient with macroalbuminuria.

Identify the need for targeted renal protection.

ACE inhibitors reduce intraglomerular pressure, offering specific renoprotection in diabetic nephropathy.

3

Analyze the patient with exertional angina and hypertension.

Identify the need to decrease myocardial oxygen demand.

Beta-blockers lower heart rate and contractility, effectively treating both hypertension and stable angina.

4

Consider the Black patient with uncomplicated hypertension.

Select a guideline-recommended first-line agent for this demographic.

Dihydropyridine calcium channel blockers provide superior blood pressure lowering in Black patients compared to ACE inhibitors when used as monotherapy.

Key Concept

Selection of antihypertensive medications must be tailored to patient-specific compelling indications, such as comorbidities (e.g., angina, diabetes with albuminuria) and demographic factors, to optimize both blood pressure control and overall outcomes.

Question 1222Question →

A 55-year-old woman undergoing induction chemotherapy for acute myeloid leukemia develops a new-onset fever of $38.9^\circ\text{C}$ ( $102.0^\circ\text{F}$ ). She has an indwelling central venous catheter, and her absolute neutrophil count is $100/\text{mm}^3$ . Arrange the following initial management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain blood cultures, immediately follow with empiric broad-spectrum antibiotics, monitor the patient while awaiting results, and finally tailor the antibiotics based on culture sensitivities.

The standard of care for febrile neutropenia requires obtaining blood cultures first (to ensure accurate microbiological diagnosis) followed immediately by the administration of empiric broad-spectrum antibiotics (to prevent septic shock). Once the patient is stabilized and on empiric therapy, the clinical team monitors the patient and awaits culture results. Finally, when sensitivities return, the antibiotic regimen is modified to target the specific organism.

Step-by-Step Solution

1

Identify the clinical emergency

The patient has neutropenic fever, an oncologic emergency requiring rapid intervention.

Profound neutropenia puts the patient at high risk for overwhelming bacterial sepsis.

2

Determine the first step before administering medications

Blood cultures must be drawn first.

Administering antibiotics before cultures can yield false-negative blood cultures.

3

Determine the immediate pharmacological intervention

Administer anti-pseudomonal broad-spectrum antibiotics.

Delaying antibiotics in febrile neutropenia significantly increases mortality.

4

Establish the follow-up steps

Wait for culture results, then de-escalate or modify therapy.

Antimicrobial stewardship dictates targeting the specific pathogen once it is identified.

Key Concept

In febrile neutropenia, blood cultures must be drawn immediately, followed promptly by the administration of empiric broad-spectrum antibiotics covering Pseudomonas, before tailoring therapy based on subsequent culture results.

Estimated Time:1m 0s

Question 1223Question →

During a routine prenatal visit at $28$ weeks gestation, a primigravid patient with a known history of systemic lupus erythematosus is evaluated. She reports new-onset exertional dyspnea and mild fatigue over the past two weeks. Her systemic lupus erythematosus has been well controlled with hydroxychloroquine for the past three years. Vital signs are within normal limits, and physical examination reveals clear lung fields bilaterally and trace dependent pedal edema.

Laboratory analysis reveals:

Parameter	Result
Hemoglobin	$10.8$ g/dL
Platelet count	$210,000$ /mm $^3$
Serum creatinine	$0.6$ mg/dL
Urinalysis	Trace protein, no cellular casts

An arterial blood gas obtained on room air demonstrates:

Parameter	Result
pH	$7.44$
pCO₂	$29$ mm Hg
pO₂	$104$ mm Hg
HCO₃⁻	$20$ mEq/L

Which of the following is the most appropriate next step in the management of this patient?

Initiate oral prednisone therapy

Administer intravenous furosemide

Reassure the patient and continue current management

Administer intravenous sodium bicarbonate

Prescribe oral amoxicillin-clavulanate

Show answer & explanation

Answer: Reassure the patient and continue current management

Answer

Reassure the patient and continue current management.

The correct approach is to reassure the patient and continue her current regimen. This patient is experiencing normal physiologic changes of pregnancy. Progesterone stimulates the medullary respiratory center, causing an increase in tidal volume and minute ventilation, which manifests as a chronic respiratory alkalosis (low pCO₂) with a compensatory metabolic acidosis (decreased HCO₃⁻). Additionally, maternal plasma volume expands more than red blood cell mass, leading to physiologic dilutional anemia. Trace pedal edema and mild exertional dyspnea are also normal as pregnancy progresses. Crucially, there is no evidence of a systemic lupus erythematosus flare; her creatinine is normal, and urinalysis shows only trace protein without cellular casts.

Step-by-Step Solution

1

Analyze the patient's symptoms and physical examination findings.

The patient has mild exertional dyspnea and trace pedal edema, which are normal, expected findings in the late second and third trimesters of pregnancy due to an expanding uterus and increased plasma volume.

To differentiate between physiologic changes of pregnancy and pathological disease processes.

2

Evaluate the laboratory and arterial blood gas results.

The patient has a mild dilutional anemia (hemoglobin

10.8

g/dL) and a chronic respiratory alkalosis (pH

7.44

, low pCO₂, low HCO₃⁻).

During pregnancy, progesterone stimulates the respiratory center, leading to increased minute ventilation and chronic respiratory alkalosis with metabolic compensation.

3

Assess for signs of a systemic lupus erythematosus flare.

The platelet count is normal, serum creatinine is normal, and urinalysis lacks cellular casts or significant proteinuria.

Lupus nephritis or a systemic flare would typically present with active urine sediment, worsening kidney function, hypertension, or severe cytopenias.

4

Determine the most appropriate management.

Because all findings are consistent with normal physiologic changes of pregnancy and there is no evidence of a lupus flare, reassurance is indicated.

Unnecessary medical interventions can cause harm to both the mother and the fetus.

Key Concept

Recognizing the normal physiologic changes of pregnancy (e.g., dilutional anemia, chronic respiratory alkalosis, trace edema) in a patient with systemic lupus erythematosus to avoid misdiagnosing a disease flare.

Estimated Time:1m 30s

Question 1224Question →

Reviewing culture data on the third day of hospitalization, an internal medicine team evaluates a 71-year-old woman admitted for severe sepsis secondary to pyelonephritis. At presentation, she had a temperature of $39.1^\circ\text{C}$ ( $102.4^\circ\text{F}$ ), a blood pressure of $88/54\text{ mmHg}$ , and severe right flank pain. She was fluid-resuscitated and started on empiric intravenous vancomycin and ceftriaxone.

Her past medical history is notable for type 2 diabetes mellitus, hypertension, and a self-reported penicillin allergy, which she describes as 'severe nausea and diarrhea' occurring after taking an antibiotic for a sinus infection 15 years ago.

Currently, the patient is clinically stable. Her temperature is $37.2^\circ\text{C}$ ( $99.0^\circ\text{F}$ ), blood pressure is $128/78\text{ mmHg}$ , and pulse is $78/\text{min}$ . The right costovertebral angle tenderness has resolved. Her white blood cell count has decreased from $18,500/\text{mm}^3$ to $8,200/\text{mm}^3$ .

Both urine and blood cultures drawn at admission are growing *Enterococcus faecalis*. The isolate is susceptible to ampicillin, vancomycin, linezolid, and daptomycin. A transesophageal echocardiogram demonstrates no evidence of valvular vegetations.

Which of the following is the most appropriate next step in this patient's antimicrobial management?

Discontinue all current antibiotics and initiate intravenous ampicillin

Discontinue ceftriaxone and continue intravenous vancomycin

Discontinue all current antibiotics and initiate intravenous piperacillin-tazobactam

Discontinue all current antibiotics and initiate intravenous daptomycin

Discontinue all current antibiotics and initiate oral linezolid

Show answer & explanation

Answer: Discontinue all current antibiotics and initiate intravenous ampicillin

Answer

Discontinue all current antibiotics and initiate intravenous ampicillin.

The correct approach is to discontinue empiric antibiotics and initiate intravenous ampicillin. This patient has *Enterococcus faecalis* bacteremia originating from pyelonephritis. The isolate is ampicillin-susceptible, making ampicillin the targeted, bactericidal drug of choice. A critical step is evaluating her 'penicillin allergy.' Nausea and diarrhea are common medication side effects, not IgE-mediated hypersensitivity reactions (like anaphylaxis, urticaria, or bronchospasm). Therefore, there is no contraindication to administering beta-lactams. Switching to ampicillin represents optimal antimicrobial stewardship by narrowing the spectrum of coverage, effectively treating the infection while minimizing the risk of developing vancomycin-resistant enterococci (VRE) or *Clostridioides difficile* infection.

Step-by-Step Solution

1

Analyze the culture and susceptibility results.

The infection is caused by Enterococcus faecalis, which is susceptible to ampicillin, vancomycin, linezolid, and daptomycin.

Identifying the organism and its susceptibilities is required to tailor empiric antimicrobial therapy to targeted therapy.

2

Evaluate the patient's reported penicillin allergy.

The patient reports 'nausea and diarrhea', which is a gastrointestinal intolerance, not a true IgE-mediated hypersensitivity or severe delayed reaction.

Determining if a true allergy exists dictates whether beta-lactam antibiotics can be safely administered.

3

Apply antimicrobial stewardship principles to select the most appropriate targeted therapy.

Intravenous ampicillin is selected as the narrowest-spectrum, most effective bactericidal agent.

De-escalating to a narrow-spectrum agent like ampicillin minimizes the risk of resistance (e.g., VRE) and toxicity compared to broad-spectrum alternatives like vancomycin or piperacillin-tazobactam.

Key Concept

Patients with a reported penicillin allergy involving only gastrointestinal intolerance can safely receive beta-lactam antibiotics. For susceptible *Enterococcus faecalis* bacteremia, ampicillin is the narrow-spectrum, bactericidal drug of choice.

Estimated Time:1m 0s

Question 1225Question →

A $34$ -year-old woman comes to the general internal medicine clinic due to a four-month history of severe fatigue, generalized weakness, and a $5$ kg ( $11$ lb) unintended weight gain. She reports that she has not had a menstrual period since the birth of her second child $14$ months ago. Her medical records indicate that the delivery was complicated by severe hemorrhage necessitating the transfusion of four units of packed red blood cells. She is currently not taking any medications. Her blood pressure is $98/60$ mm Hg, and her pulse is $54$ /min. Physical examination demonstrates pale, dry skin and a delayed relaxation phase of the Achilles tendon reflexes.

Laboratory results are as follows:

Test	Result	Reference Range
Hemoglobin	$11.2$ g/dL	$12.0 - 15.5$ g/dL
Thyroid-stimulating hormone (TSH)	$0.3$ $\mu$ U/mL	$0.5 - 5.0$ $\mu$ U/mL
Free thyroxine (T4)	$0.5$ ng/dL	$0.9 - 1.7$ ng/dL

Which of the following is the most appropriate next step in the management of this patient?

Initiate oral levothyroxine monotherapy

Evaluate early morning serum cortisol and adrenocorticotropic hormone

Obtain a diagnostic ultrasound of the thyroid gland

Measure serum thyroid-stimulating immunoglobulin

Recommend symptomatic treatment and repeat the thyroid panel in 6 weeks

Show answer & explanation

Answer: Evaluate early morning serum cortisol and adrenocorticotropic hormone

Answer

Evaluate early morning serum cortisol and adrenocorticotropic hormone

The patient's history of postpartum hemorrhage followed by amenorrhea, fatigue, and weight gain is classic for Sheehan syndrome (ischemic necrosis of the pituitary gland). The laboratory findings of a low free T4 alongside an inappropriately low TSH confirm secondary (central) hypothyroidism. When central hypothyroidism is diagnosed, it is imperative to evaluate the adrenal axis (cortisol and ACTH) before administering thyroid hormone replacement. Levothyroxine increases the basal metabolic rate and enhances the hepatic clearance of glucocorticoids; if administered to a patient with concurrent, untreated adrenal insufficiency, it can precipitate a life-threatening acute adrenal crisis.

Step-by-Step Solution

1

Interpret the thyroid function tests

Low TSH and low free T4

To differentiate between primary and secondary (central) hypothyroidism

2

Correlate with clinical history

Suspect Sheehan syndrome (postpartum pituitary necrosis)

The patient has central hypothyroidism, amenorrhea, and a history of severe postpartum hemorrhage

3

Determine the necessary safety step before treating central hypothyroidism

Evaluate the adrenal axis

Initiating levothyroxine in a patient with unrecognized central adrenal insufficiency can precipitate an acute adrenal crisis

Key Concept

In patients with suspected secondary (central) hypothyroidism and potential panhypopituitarism, the adrenal axis must be evaluated before initiating levothyroxine to avoid precipitating an acute adrenal crisis.

Question 1226Question →

Match the following clinical exposure scenarios with their most appropriate post-exposure prophylaxis or empiric treatment regimen.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Meningococcal contact requires Rifampin/Ciprofloxacin/Ceftriaxone; Cat bite requires Amoxicillin-clavulanate; High-risk tick bite requires single-dose Doxycycline; HIV needlestick requires Three-drug antiretroviral therapy.

Each exposure corresponds to a specific, evidence-based prophylactic or early treatment regimen designed to eradicate the most likely transmitted pathogen before an active infection becomes established.

Step-by-Step Solution

1

Analyze each exposure scenario to identify the primary pathogen of concern.

Pathogens identified include Neisseria meningitidis, Pasteurella multocida, Borrelia burgdorferi, and HIV.

Accurate pathogen identification dictates the choice of targeted prophylaxis.

2

Select the guideline-recommended prophylactic or empiric regimen for each identified pathogen risk.

Matched the appropriate antimicrobial or antiretroviral regimen to each specific exposure.

Prophylaxis must target the specific organism's susceptibilities to effectively prevent disease development.

Key Concept

Post-exposure prophylaxis and early empiric treatment regimens for common infectious exposures.

Question 1227Question →

A $54$ -year-old female patient presents to the outpatient clinic reporting a $3$ -month history of decreased energy and generalized weakness. She states that she struggles to complete her usual daily tasks. The patient has a $5$ -year history of rheumatoid arthritis but stopped taking her prescribed medications $6$ months ago due to a lapse in health insurance. She currently takes only ibuprofen occasionally for joint pain.

Vital signs are within normal limits. Physical examination reveals pale conjunctivae. Her bilateral metacarpophalangeal and proximal interphalangeal joints are swollen, warm, and tender to palpation.

Laboratory evaluation reveals the following:

Parameter	Result	Reference Range
Hemoglobin	$9.8$ g/dL	$12.0 - 16.0$ g/dL
Mean corpuscular volume	$81$ fL	$80 - 100$ fL
Leukocyte count	$9,200$ /mm $^3$	$4,500 - 11,000$ /mm $^3$
Platelet count	$450,000$ /mm $^3$	$150,000 - 400,000$ /mm $^3$
Reticulocyte count	$0.9$ %	$0.5$ % - $1.5$ %
Serum iron	$40$ µg/dL	$50 - 170$ µg/dL
Total iron-binding capacity (TIBC)	$220$ µg/dL	$250 - 450$ µg/dL
Serum ferritin	$410$ ng/mL	$15 - 200$ ng/mL

Which of the following is the most appropriate management for this patient's anemia?

Initiation of daily oral ferrous sulfate

Infusion of intravenous iron dextran

Administration of recombinant human erythropoietin

Transfusion of one unit of packed red blood cells

Optimization of disease-modifying antirheumatic therapy

Show answer & explanation

Answer: Optimization of disease-modifying antirheumatic therapy

Answer

The correct answer is optimization of disease-modifying antirheumatic therapy.

The most appropriate management for this patient's anemia is optimization of disease-modifying antirheumatic therapy. This patient's laboratory findings (low serum iron, low TIBC, and elevated ferritin) in the setting of poorly controlled rheumatoid arthritis are pathognomonic for anemia of chronic disease (ACD). Chronic inflammatory states trigger the hepatic production of hepcidin. Hepcidin binds and degrades ferroportin on enterocytes and macrophages, preventing both intestinal iron absorption and the release of iron from storage sites. This creates a state of functional iron deficiency despite adequate total body iron stores (indicated by the elevated ferritin). The most effective initial treatment for ACD is resolving the underlying inflammatory condition, which in this case involves restarting appropriate disease-modifying antirheumatic drugs (DMARDs).

Step-by-Step Solution

1

Analyze the patient's laboratory findings in the context of her clinical presentation.

The laboratory profile shows a normocytic anemia with low serum iron, low total iron-binding capacity (TIBC), and elevated serum ferritin.

Identifying the exact pattern of iron studies is essential to distinguish between iron deficiency anemia and anemia of chronic disease.

2

Synthesize the laboratory data with the patient's medical history.

The patient has poorly controlled rheumatoid arthritis, an inflammatory condition that causes hepcidin release, which perfectly matches the laboratory pattern of anemia of chronic disease (ACD).

Establishing the precise etiology of the anemia dictates the appropriate therapeutic intervention.

3

Determine the most appropriate management for anemia of chronic disease.

The primary and most effective treatment for ACD is optimizing the management of the underlying inflammatory disorder.

Reducing inflammation decreases hepcidin levels, which subsequently restores normal iron mobilization and improves erythropoiesis.

Key Concept

Anemia of chronic disease is characterized by low serum iron, low TIBC, and elevated ferritin due to hepcidin-mediated iron sequestration. The primary treatment is addressing the underlying inflammatory condition.

Estimated Time:1m 30s

Question 1228Question →

A 68-year-old man is evaluated in the surgical intensive care unit on postoperative day 7 following a coronary artery bypass graft. He has been receiving prophylactic subcutaneous unfractionated heparin since surgery. His temperature is $37.1^\circ C$ ( $98.8^\circ F$ ), blood pressure is $135/85$ mmHg, pulse is $92$ /min, and respiratory rate is $16$ /min. His preoperative platelet count was $260,000/mm^3$ . Today, his routine complete blood count reveals a platelet count of $85,000/mm^3$ . Physical examination is notable for new right calf swelling and a necrotic skin lesion at a recent heparin injection site on his abdomen. A lower extremity venous duplex ultrasound is performed, which reveals a noncompressible right popliteal vein consistent with a deep vein thrombosis. The patient's 4T score is calculated as 7, indicating a high clinical probability for heparin-induced thrombocytopenia (HIT).

Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for this patient's management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first discontinue all heparin products, then initiate a non-heparin anticoagulant, followed by definitive laboratory confirmation of HIT, and finally transition to warfarin only after platelet recovery.

The correct sequence for managing highly suspected Heparin-Induced Thrombocytopenia (HIT) emphasizes immediate clinical intervention over delayed diagnostic certainty. The first step is the absolute cessation of all heparin products to eliminate the immunogenic trigger. Second, because HIT is an intensely prothrombotic state (evidenced here by a new DVT despite thrombocytopenia), empiric therapeutic anticoagulation with a non-heparin agent (like argatroban or bivalirudin) must be initiated immediately. Third, laboratory confirmation using screening and highly specific functional tests (such as the Serotonin Release Assay) is pursued while the patient is safely anticoagulated. Finally, bridging to oral warfarin is delayed until the acute phase resolves (platelet count

\geq 150,000/mm^3

) to avoid the dreaded complication of warfarin-induced venous limb gangrene.

Step-by-Step Solution

1

Recognize high-probability Heparin-Induced Thrombocytopenia (HIT).

Identify the need for immediate intervention without waiting for laboratory confirmation.

A 4T score of 7 indicates a high clinical probability of HIT, necessitating emergency management to prevent catastrophic thrombosis.

2

Place 'Discontinue all heparin-containing medications...' as the first step.

Removal of the immunogenic trigger.

Halting the exposure to heparin is the primary requirement to stop the formation of PF4-heparin antibody complexes.

3

Place 'Initiate therapeutic anticoagulation with a non-heparin parenteral agent...' as the second step.

Immediate empiric treatment of the prothrombotic state.

Patients with HIT have a 50% risk of developing a new thrombosis if untreated; non-heparin anticoagulation must be started empirically before diagnostic assays result.

4

Place 'Confirm the diagnosis...' as the third step, and 'Transition to oral warfarin...' as the final step.

Appropriate diagnostic follow-up and safe long-term management.

Diagnostic confirmation occurs concurrently with treatment, and warfarin cannot be started until platelets recover to

\geq 150,000/mm^3

due to the risk of venous limb gangrene.

Key Concept

In highly suspected Heparin-Induced Thrombocytopenia (HIT), all heparin must be stopped immediately and a non-heparin anticoagulant started empirically; warfarin is contraindicated until the platelet count has fully recovered.

Estimated Time:1m 30s

Question 1229Question →

Match each patient's clinical presentation and peripheral blood smear findings with the most appropriate definitive antimalarial treatment regimen.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches synthesize the Plasmodium species identified via smear morphology, clinical severity, regional resistance patterns, and the presence of a hypnozoite phase to assign the definitive pharmacological regimen.

The correct pairings require precise synthesis of microbiologic findings (smear morphology), clinical status (severe vs. uncomplicated), and geographic resistance data. Severe P. falciparum requires IV artesunate. Uncomplicated CQ-resistant P. falciparum requires oral ACT. P. vivax requires CQ plus primaquine for hypnozoites. P. malariae requires only CQ.

Step-by-Step Solution

1

Evaluate the first scenario (Nigeria).

Identified as severe P. falciparum based on >10% parasitemia, CNS symptoms, acute kidney injury, and crescent gametocytes.

Determining species and severity dictates the urgent need for intravenous artesunate therapy.

2

Evaluate the second scenario (Honduras).

Identified as P. vivax based on 48-hour fevers, enlarged RBCs, and Schüffner's dots.

P. vivax has a dormant liver stage (hypnozoites) requiring specific anti-relapse therapy with primaquine in addition to chloroquine.

3

Evaluate the third scenario (Thailand).

Identified as uncomplicated P. falciparum from a chloroquine-resistant region based on 1.5% parasitemia and appliqué rings.

Requires an oral artemisinin-based combination therapy; no primaquine is needed as there is no liver stage.

4

Evaluate the fourth scenario (Caribbean).

Identified as P. malariae based on 72-hour fever cycles and band-like trophozoites.

Indicates a chloroquine-sensitive strain with no liver stage, treated definitively with chloroquine monotherapy.

Key Concept

Diagnosis and targeted pharmacotherapy of malaria based on Plasmodium species morphology, clinical severity, geographic resistance patterns, and the presence of a hypnozoite phase.

Estimated Time:2m 30s

Question 1230Question →

Match each patient vignette presenting with a complex bleeding or thrombotic complication to the most appropriate targeted therapy or management strategy.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Vignette 1 matches 'Administer recombinant factor VIIa or activated prothrombin complex concentrate'. Vignette 2 matches 'Initiate lifelong therapeutic anticoagulation with a vitamin K antagonist'. Vignette 3 matches 'Administer von Willebrand factor concentrate and specifically avoid desmopressin (DDAVP)'. Vignette 4 matches 'Administer platelet transfusions for acute severe bleeding episodes'.

Each correct pairing directly links a highly specific and complex laboratory profile to its exact diagnosis and corresponding life-saving or disease-modifying therapy, requiring multi-step pathophysiologic reasoning.

Step-by-Step Solution

1

Analyze the mixing study and coagulation profile in the first vignette.

A time-dependent inhibitor is identified, characteristic of an acquired factor VIII autoantibody.

To determine that standard factor VIII replacement will fail and bypassing agents are required.

2

Evaluate the coagulation profile and clinical history in the second vignette.

A phospholipid-dependent immediate inhibitor is identified in a patient with DVT and miscarriages, diagnosing Antiphospholipid Syndrome.

To identify that lifelong vitamin K antagonist anticoagulation is required for secondary thrombosis prevention.

3

Assess the platelet aggregometry and VWF studies in the third vignette.

Enhanced aggregation with low-dose ristocetin confirms Type 2B VWD.

To recognize that DDAVP is contraindicated and exogenous VWF concentrate must be utilized.

4

Analyze the peripheral smear and aggregation studies in the fourth vignette.

Macrothrombocytopenia with absent ristocetin aggregation unresponsive to normal plasma confirms Bernard-Soulier syndrome.

To determine that because the defect is intrinsic to the platelets, platelet transfusion is the definitive therapy.

Key Concept

Interpretation of advanced coagulation assays (immediate vs. incubated mixing studies, phospholipid dependence) and specialized platelet aggregometry is required to diagnose complex acquired and congenital hematologic disorders and select appropriate targeted therapies.

Estimated Time:3m 0s

Question 1231Question →

A 45-year-old woman is brought to the emergency department because of a severe, throbbing headache and blurred vision that began earlier today. She was diagnosed with diffuse cutaneous systemic sclerosis 8 months ago. Her symptoms include progressive skin thickening over her face, trunk, and extremities, as well as severe Raynaud phenomenon. Her only medication is omeprazole. Her temperature is 37.1°C (98.8°F), blood pressure is 224/118 mm Hg, pulse is 98/min, and respirations are 16/min. Physical examination shows taut, thickened skin over the fingers, hands, arms, and anterior chest, along with multiple telangiectasias. Funduscopic examination reveals bilateral papilledema. Laboratory studies show:

Urinalysis shows 1+ protein and no red blood cell casts. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Administer oral captopril

Initiate therapeutic plasma exchange

Administer intravenous methylprednisolone

Administer intravenous labetalol

Administer intravenous nitroprusside

Show answer & explanation

Answer: Administer oral captopril

Answer

Administer oral captopril

This patient has scleroderma renal crisis (SRC), a severe and life-threatening complication seen most commonly in patients with diffuse cutaneous systemic sclerosis, particularly within the first few years of disease onset. The pathogenesis involves intimal thickening and proliferation of the renal arcuate and interlobular arteries. This structural change leads to profound renal ischemia, which triggers massive release of renin and extreme activation of the renin-angiotensin-aldosterone system (RAAS). Clinically, SRC presents with acute malignant hypertension (often with hypertensive encephalopathy or papilledema), acute kidney injury, and frequently a microangiopathic hemolytic anemia (MAHA) characterized by schistocytes and thrombocytopenia. Because the entire crisis is driven by pathological renin release, angiotensin-converting enzyme (ACE) inhibitors are the specific, life-saving treatment of choice. Oral captopril is preferred over other agents due to its rapid onset and short half-life, allowing for safe and rapid dose titration. Crucially, ACE inhibitors must be initiated and up-titrated even in the presence of an acute elevation in serum creatinine, a scenario where ACE inhibitors are generally withheld in other forms of acute kidney injury.

Step-by-Step Solution

1

Analyze the patient's clinical presentation and history.

The patient has a recent diagnosis of diffuse cutaneous systemic sclerosis and presents with malignant hypertension (papilledema), acute kidney injury, and microangiopathic hemolytic anemia.

Identifying the underlying rheumatologic condition provides the essential context for interpreting the acute end-organ failure.

2

Formulate a diagnosis based on the clinical triad.

The triad of systemic sclerosis, malignant hypertension, and acute kidney injury is the classic presentation of scleroderma renal crisis (SRC).

SRC is a life-threatening complication that requires immediate, disease-specific therapy rather than generic management.

3

Determine the pathophysiologic mechanism of the disease.

SRC is driven by intimal proliferation and narrowing of renal arterioles, leading to severe renal ischemia and subsequent massive, extreme activation of the renin-angiotensin-aldosterone system (RAAS).

Understanding the renin-driven mechanism directs the clinician toward the correct class of pharmacotherapy.

4

Select the most appropriate initial pharmacological intervention.

An ACE inhibitor, specifically short-acting oral captopril, is the treatment of choice to rapidly reverse the RAAS activation. It must be initiated immediately, even when the serum creatinine is significantly elevated.

ACE inhibitors are the only class of medications proven to improve mortality and long-term renal outcomes in SRC.

Key Concept

Scleroderma renal crisis presents with acute malignant hypertension and acute kidney injury in a patient with diffuse cutaneous systemic sclerosis. The cornerstone of treatment is the immediate initiation of an ACE inhibitor (e.g., captopril) to reverse extreme RAAS activation, despite the presence of acute kidney injury.

Estimated Time:1m 30s

Question 1232Question →

A 24-year-old man comes to the clinic due to a sore on his penis that he noticed 5 days ago. He reports no pain, itching, or penile discharge. He is sexually active with a new male partner and does not use condoms consistently. Vital signs are within normal limits. Physical examination reveals a single, 1.5-cm, sharply circumscribed, indurated, and painless ulcer on the penile shaft. Bilateral, non-tender inguinal lymphadenopathy is present. Which of the following is the most appropriate pharmacotherapy for this patient?

Intramuscular ceftriaxone

Oral acyclovir

Intramuscular benzathine penicillin G

Oral azithromycin

Intravenous aqueous penicillin G

Show answer & explanation

Answer: Intramuscular benzathine penicillin G

Answer

Intramuscular benzathine penicillin G

The patient's painless, indurated genital ulcer with non-tender inguinal lymphadenopathy is the classic presentation of a primary syphilitic chancre, caused by the spirochete Treponema pallidum. The most appropriate first-line treatment for primary, secondary, and early latent syphilis is a single dose of intramuscular benzathine penicillin G.

Step-by-Step Solution

1

Analyze the clinical presentation of the genital ulcer.

The patient has a single, indurated, sharply circumscribed, and painless ulcer accompanied by non-tender inguinal lymphadenopathy.

Identifying the specific characteristics of genital ulcers (painful vs. painless, single vs. multiple, purulent vs. clean) is essential for diagnosing the underlying sexually transmitted infection.

2

Formulate the most likely diagnosis.

The classic presentation of a painless chancre indicates primary syphilis caused by Treponema pallidum.

Other common causes of genital ulcers, such as herpes simplex virus and Haemophilus ducreyi, typically present with painful lesions.

3

Select the appropriate pharmacotherapy based on the diagnosis.

Intramuscular benzathine penicillin G is selected.

A single dose of long-acting intramuscular benzathine penicillin G is the standard of care and highly effective first-line therapy for primary, secondary, and early latent syphilis.

Key Concept

The hallmark of primary syphilis is a painless, indurated genital chancre, and the standard first-line treatment is a single dose of intramuscular benzathine penicillin G.

Estimated Time:45s

Question 1233Question →

A 68-year-old female presents to the outpatient clinic reporting progressive fatigue and shortness of breath with minimal exertion over the past three months. Her past medical history includes chronic obstructive pulmonary disease and primary hypothyroidism. Her current medications include inhaled tiotropium and oral levothyroxine. Vital signs are within normal limits. Pulse oximetry is $96\%$ on room air. Physical examination reveals marked conjunctival pallor. Lung fields are clear to auscultation bilaterally, and there is no jugular venous distention or peripheral edema.

Laboratory studies reveal the following:
Hemoglobin: $7.1\text{ g/dL}$
Mean corpuscular volume: $115\text{ fL}$
White blood cell count: $4,500/\text{mm}^3$
Platelet count: $160,000/\text{mm}^3$
Thyroid-stimulating hormone: $2.4\text{ }\mu\text{U/mL}$ (normal: $0.4-4.0\text{ }\mu\text{U/mL}$ )

Which of the following is the most appropriate next step in management?

Measure serum vitamin B12 and folate levels

Increase the daily dosage of levothyroxine

Prescribe an oral macrolide antibiotic and a corticosteroid burst

Perform an echocardiogram and initiate a loop diuretic

Obtain an arterial blood gas to assess acid-base status

Show answer & explanation

Answer: Measure serum vitamin B12 and folate levels

Answer

Measure serum vitamin B12 and folate levels

The correct answer accurately identifies the next step for a patient presenting with an elevated mean corpuscular volume (MCV > 100 fL). The most common causes of macrocytic anemia are vitamin B12 and folate deficiencies, and these levels should be obtained as the first step in the diagnostic workup.

Step-by-Step Solution

1

Identify the primary clinical abnormality based on laboratory findings.

The patient has symptomatic severe anemia (hemoglobin

7.1\text{ g/dL}

) with macrocytosis (mean corpuscular volume

115\text{ fL}

).

Recognizing the predominant laboratory abnormality directs the diagnostic algorithm.

2

Evaluate the clinical presentation against the patient's comorbidities.

The normal thyroid-stimulating hormone rules out uncontrolled hypothyroidism. The clear lungs and normal oxygen saturation rule out an acute cardiopulmonary exacerbation.

This ensures that symptoms of fatigue and dyspnea are correctly attributed to the anemia rather than chronic diseases.

3

Select the appropriate initial test for the identified anemia.

Vitamin B12 and folate levels are indicated.

These are the most common causes of macrocytic anemia and must be evaluated first to guide definitive therapy.

Key Concept

The initial diagnostic step for macrocytic anemia (elevated mean corpuscular volume) includes checking serum vitamin B12 and folate levels.

Question 1234Question →

A 65-year-old man with a history of metastatic prostate cancer presents to the emergency department with a 2-day history of progressive lower extremity weakness, sensory loss below the umbilicus, and new-onset urinary retention. Physical examination reveals paraparesis, hyperreflexia in both lower extremities, and decreased rectal sphincter tone. Arrange the following steps in the most appropriate chronological sequence for the evaluation and management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management is to first administer intravenous dexamethasone, followed by an MRI of the entire spine, then obtain surgical and radiation oncology consultations, and finally proceed with definitive decompression or radiation therapy.

The patient's clinical presentation is highly suspicious for malignant epidural spinal cord compression (ESCC), a true oncologic emergency. The primary goal of initial management is to prevent irreversible neurologic loss. Therefore, the immediate first step is the administration of high-dose intravenous corticosteroids (e.g., dexamethasone) to decrease vasogenic edema around the spinal cord. Once steroids are given, the diagnosis must be confirmed and localized with an urgent MRI of the entire spine. Following MRI confirmation, urgent consultations with neurosurgery and radiation oncology are needed to determine the optimal definitive intervention, which is then executed as the final step in the sequence.

Step-by-Step Solution

1

Recognize the clinical presentation of epidural spinal cord compression (ESCC).

The patient's history of prostate cancer, rapidly progressive paraparesis, sensory level, and bowel/bladder dysfunction strongly indicate ESCC.

Identifying this presentation as an acute oncologic emergency dictates the urgency of subsequent management steps to prevent permanent paralysis.

2

Prioritize immediate neurologic preservation over diagnostic confirmation.

High-dose intravenous dexamethasone is administered as the very first step.

Corticosteroids rapidly reduce vasogenic edema surrounding the spinal cord, relieving pressure and preventing irreversible neurologic ischemia.

3

Obtain diagnostic confirmation and anatomical localization.

Urgent MRI of the entire spine is performed.

MRI is required to visualize the exact location and extent of the tumor, which is essential for planning subsequent interventions.

4

Formulate and execute a definitive multidisciplinary treatment plan.

Specialists are consulted, followed by surgical decompression or primary radiation therapy.

Definitive management depends on multiple variables (e.g., spinal instability, tumor radiosensitivity, patient prognosis), requiring specialized surgical and oncologic expertise.

Key Concept

In patients with suspected malignant epidural spinal cord compression presenting with neurologic deficits, immediate administration of high-dose corticosteroids is the absolute first step in management, which must occur prior to confirmatory imaging with an MRI.

Question 1235Question →

A $58$ -year-old man is evaluated in the intensive care unit for worsening respiratory status. Eight days ago, he was intubated following a severe motor vehicle collision. Over the past $24$ hours, his oxygen requirements have increased, and he has developed a fever of $38.9^\circ\text{C}$ ( $102.0^\circ\text{F}$ ). Copious thick, purulent secretions are noted in the endotracheal tube. Physical examination reveals coarse rhonchi over the right lung field. Laboratory studies show a leukocyte count of $16,500/\text{mm}^3$ with $85\%$ neutrophils. A chest radiograph demonstrates a new dense consolidation in the right lower lobe. The patient was empirically started on intravenous vancomycin, piperacillin-tazobactam, and amikacin.

Today, the quantitative endotracheal aspirate culture returns positive for $>10^5\text{ CFU/mL}$ of *Pseudomonas aeruginosa*. The isolate is susceptible to piperacillin-tazobactam, cefepime, meropenem, and amikacin. Blood cultures show no growth. His serum creatinine has increased from $1.0\text{ mg/dL}$ on admission to $2.3\text{ mg/dL}$ today.

Which of the following is the most appropriate next step in pharmacotherapy?

Continue vancomycin, piperacillin-tazobactam, and amikacin

Discontinue vancomycin; continue piperacillin-tazobactam and amikacin

Discontinue vancomycin and amikacin; continue piperacillin-tazobactam

Discontinue vancomycin and piperacillin-tazobactam; initiate meropenem

Discontinue vancomycin and piperacillin-tazobactam; continue amikacin

Show answer & explanation

Answer: Discontinue vancomycin and amikacin; continue piperacillin-tazobactam

Answer

The most appropriate next step is to discontinue vancomycin and amikacin, and continue piperacillin-tazobactam monotherapy.

The correct answer discontinues both vancomycin and amikacin while continuing piperacillin-tazobactam. This patient developed ventilator-associated pneumonia (VAP), and empiric therapy appropriately included coverage for MRSA (vancomycin) and dual coverage for Pseudomonas (piperacillin-tazobactam and amikacin). Once culture and susceptibility results are available, therapy must be de-escalated to targeted treatment. Since no MRSA was isolated, vancomycin should be stopped. For definitive therapy of P. aeruginosa VAP, once in vitro susceptibility to a beta-lactam (like piperacillin-tazobactam) is confirmed, double coverage with an aminoglycoside is no longer recommended because it does not improve outcomes and increases the risk of toxicity. Given this patient's rising creatinine (acute kidney injury), discontinuing the nephrotoxic aminoglycoside is especially critical. Therefore, monotherapy with piperacillin-tazobactam is the most appropriate definitive step.

Step-by-Step Solution

1

Interpret the clinical presentation and culture results.

The patient has ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa, which is susceptible to piperacillin-tazobactam.

Establishing the definitive microbiological diagnosis is required to tailor antimicrobial therapy.

2

Evaluate the indication for continuing methicillin-resistant Staphylococcus aureus (MRSA) coverage.

Discontinue vancomycin.

The respiratory culture did not grow MRSA, making ongoing empiric coverage unnecessary and contrary to antibiotic stewardship principles.

3

Determine the optimal antipseudomonal regimen based on susceptibilities and patient factors.

Discontinue amikacin and maintain piperacillin-tazobactam monotherapy.

Dual antipseudomonal therapy is not indicated once in vitro susceptibility to a beta-lactam is confirmed. Stopping the aminoglycoside is especially critical given the patient's acute kidney injury.

Key Concept

Definitive management of Ventilator-Associated Pneumonia (VAP) requires de-escalating from broad-spectrum empiric therapy to targeted monotherapy once pathogen susceptibilities are identified.

Question 1236Question →

Match each inpatient clinical scenario with the most appropriate targeted pharmacologic intervention based on current clinical guidelines.

Click a left item, then click its matching right item

Show answer & explanation

Answer

ESBL pneumonia is treated with meropenem; invasive pulmonary aspergillosis presenting with a halo sign requires voriconazole; severe C. difficile infection mandates oral fidaxomicin; and high-MIC MRSA endocarditis requires switching to daptomycin.

Each clinical scenario requires a critical deviation from standard empiric broad-spectrum therapy based on diagnostic clues: carbapenems for confirmed ESBL exposure, voriconazole for the characteristic fungal 'halo sign', fidaxomicin for severe toxin-mediated colitis, and daptomycin for highly resistant MRSA bacteremia.

Step-by-Step Solution

1

Analyze each patient's clinical presentation, laboratory data, and radiographic imaging to definitively diagnose the specific pathogen or pathological complication.

Identified: ESBL Klebsiella pneumonia, invasive pulmonary aspergillosis, severe C. difficile colitis, and high-MIC MRSA endocarditis.

Accurate identification of the underlying pathology and specific resistance mechanism is mandatory before selecting definitive targeted therapy.

2

Determine the optimal targeted therapeutic agent based on antimicrobial stewardship principles, site of infection, and resistance patterns.

Matched the ESBL pathogen to carbapenems, aspergillosis to voriconazole, severe C. difficile to fidaxomicin, and high-MIC MRSA to daptomycin.

Prescribing inappropriate antimicrobial therapies leads to treatment failure, compounding toxicity, and the promotion of further multidrug resistance.

Key Concept

Targeted antimicrobial therapy for severe, resistant, and opportunistic nosocomial infections

Question 1237Question →

In the management of systemic autoimmune and inflammatory diseases, disease-modifying antirheumatic drugs (DMARDs) and biologic therapies are mainstays of treatment. However, their use is associated with unique adverse effects that require specific screening and monitoring strategies. Match each medication below with its most characteristic adverse effect profile or required screening parameter.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Hydroxychloroquine matches with retinopathy; Methotrexate matches with hepatotoxicity, stomatitis, and macrocytic anemia; Cyclophosphamide matches with hemorrhagic cystitis; Adalimumab matches with reactivation of latent tuberculosis.

The correct pairings align each rheumatologic medication with its well-established mechanism of toxicity and corresponding monitoring requirement. Hydroxychloroquine accumulates in the retina, causing maculopathy. Methotrexate depletes folate, leading to mucosal and hepatic toxicity. Cyclophosphamide's metabolite acrolein damages the bladder mucosa. Adalimumab inhibits TNF-alpha, which is essential for maintaining granulomas, thus risking the reactivation of latent tuberculosis.

Step-by-Step Solution

1

Identify the primary toxicity profile of Hydroxychloroquine.

Matches with retinopathy requiring regular ophthalmologic screening.

The drug binds to melanin in the retinal pigment epithelium, causing cumulative and potentially irreversible damage.

2

Identify the primary toxicity profile of Methotrexate.

Matches with hepatotoxicity, stomatitis, and macrocytic anemia.

It is a folate antimetabolite; its adverse effects are often mitigated by concurrent folic acid supplementation.

3

Identify the primary toxicity profile of Cyclophosphamide.

Matches with hemorrhagic cystitis and increased risk of bladder carcinoma.

The toxic metabolite acrolein concentrates in the urinary bladder. Mesna and adequate hydration are used for prophylaxis.

4

Identify the primary toxicity profile of Adalimumab.

Matches with reactivation of latent tuberculosis or fungal infections.

As a TNF-alpha inhibitor, it disrupts granuloma integrity, making pre-treatment screening for latent tuberculosis (e.g., interferon-gamma release assay) essential.

Key Concept

Pharmacologic adverse effects and monitoring requirements of DMARDs and biologic agents in rheumatologic diseases.

Question 1238Question →

A 35-year-old woman is evaluated in the clinic for progressively worsening pain and color changes in her fingers. She has a known history of diffuse cutaneous systemic sclerosis. She describes her fingers turning white, then blue, and finally red upon exposure to cold. These episodes are now occurring even in mildly cool environments and are severely impacting her daily activities. Physical examination reveals thickened skin over her hands and forearms, as well as tiny, pitted scars on the distal fingertips. She asks about the therapeutic options available for her condition as it progresses.

Arrange the following interventions in the standard stepwise order of therapeutic escalation for the management of Raynaud phenomenon, from the initial approach to the final option for medically refractory, critical ischemia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The standard step-wise escalation for Raynaud phenomenon begins with nonpharmacologic measures, followed by dihydropyridine calcium channel blockers, then PDE-5 inhibitors. For severe or threatening ischemia, intravenous prostacyclin analogs are utilized, with digital sympathectomy reserved as a last resort.

The correct sequence reflects the escalating severity of Raynaud phenomenon and the risk-benefit ratio of available therapies. Initial management universally requires nonpharmacologic measures (e.g., ambient warming, avoiding triggers). When symptoms persist, dihydropyridine calcium channel blockers (CCBs) are the established first-line pharmacotherapy due to their strong efficacy and safety profile. If CCBs are insufficient, phosphodiesterase-5 (PDE-5) inhibitors are added as second-line oral therapy. For patients who develop severe, critical digital ischemia or active ulceration despite oral therapies, hospitalization for intravenous prostacyclin analogs (e.g., epoprostenol) is indicated. Finally, if critical ischemia is refractory to maximal medical management, a localized surgical digital sympathectomy is performed as a last resort to prevent digital amputation.

Step-by-Step Solution

1

Identify the primary clinical problem requiring management.

The patient has severe secondary Raynaud phenomenon due to systemic sclerosis.

Recognizing the underlying condition and severity establishes the specific treatment pathway.

2

Determine the universal first-line intervention.

Nonpharmacologic lifestyle modifications.

Avoiding cold triggers and vasoconstrictors (like nicotine) is foundational and must be optimized for all patients.

3

Identify the first-line pharmacologic therapy.

Dihydropyridine calcium channel blockers.

Oral vasodilators like nifedipine are the established standard of care for initial medical therapy.

4

Identify the appropriate second-line escalation for refractory symptoms.

PDE-5 inhibitors.

Agents like sildenafil provide additional, complementary vasodilation when monotherapy fails.

5

Determine the approach for critical, limb-threatening ischemia.

Intravenous prostacyclin analogs, followed by digital sympathectomy if medical therapy fails.

These high-risk interventions are reserved specifically for impending tissue loss or active digital ulcers.

Key Concept

Stepwise escalation of therapy for secondary Raynaud phenomenon in systemic sclerosis.

Question 1239Question →

A 65-year-old man is hospitalized for community-acquired pneumonia. Upon admission, he was empirically started on intravenous ceftriaxone and azithromycin. Two days later, his clinical condition has significantly improved. He is now afebrile, his oxygen saturation is 96% on room air, and his cough has decreased. He is eating well and tolerating oral intake. Sputum culture results return positive for Streptococcus pneumoniae. Susceptibility testing shows the organism is highly sensitive to penicillin, amoxicillin, ceftriaxone, and levofloxacin. Which of the following is the most appropriate next step in pharmacotherapy?

Transition to oral amoxicillin

Continue intravenous ceftriaxone and azithromycin

Transition to oral levofloxacin

Transition to oral amoxicillin-clavulanate

Add oral clindamycin to the current regimen

Show answer & explanation

Answer: Transition to oral amoxicillin

Answer

Transition to oral amoxicillin

The patient has community-acquired pneumonia that has clinically improved, and he is now able to tolerate oral intake. This marks the appropriate time to transition from intravenous to oral antibiotics. Furthermore, culture results show Streptococcus pneumoniae that is highly sensitive to amoxicillin. According to principles of antibiotic stewardship, therapy should be de-escalated to the narrowest spectrum agent that is effective. Oral amoxicillin perfectly fits these criteria, minimizing the risk of adverse effects and antimicrobial resistance.

Step-by-Step Solution

1

Evaluate the patient's clinical trajectory.

The patient is afebrile, oxygenating well on room air, and tolerating oral intake, indicating readiness to switch from intravenous to oral therapy.

Clinical stability dictates whether a patient can be safely de-escalated to oral antibiotics.

2

Analyze the culture and susceptibility data.

Sputum culture confirms Streptococcus pneumoniae that is sensitive to penicillin and amoxicillin.

Culture data allows for de-escalation from empiric broad-spectrum coverage to targeted narrow-spectrum therapy.

3

Select the most appropriate targeted therapy.

Oral amoxicillin provides the narrowest effective spectrum for this pathogen in an orally bioavailable form.

Antibiotic stewardship principles require using the narrowest spectrum, most effective, and least toxic agent available.

Key Concept

Antibiotic stewardship and de-escalation in community-acquired pneumonia

Question 1240Question →

A 54-year-old woman is evaluated on the general medical ward for new-onset chills and a temperature of 38.8°C (101.8°F). She recently completed her second cycle of systemic chemotherapy for invasive ductal carcinoma. Laboratory studies demonstrate a white blood cell count of 900/mm³ and an absolute neutrophil count of 250/mm³. Her blood pressure is 110/70 mm Hg, pulse is 105/min, and respiratory rate is 18/min. Physical examination reveals an indwelling central venous port in the right upper chest with no overlying erythema, fluctuance, or tenderness. The remainder of the examination is unremarkable.

Arrange the following steps in the most appropriate chronological order for the acute diagnostic and therapeutic management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first obtain peripheral and central blood cultures, followed immediately by empiric antipseudomonal beta-lactam antibiotics. The patient is then monitored for 48 to 72 hours on this initial regimen, and an empiric antifungal agent is added only if fever persists beyond 4 to 7 days.

The management of neutropenic fever relies on a protocolized sequence to balance the risk of overwhelming sepsis against antimicrobial stewardship principles. Because these patients lack a robust inflammatory response, infections can progress rapidly. The immediate first step is obtaining blood cultures (including from any central lines) to maximize pathogen recovery. Immediately after cultures are drawn, broad-spectrum empiric antibiotics with antipseudomonal coverage (e.g., cefepime, meropenem) must be initiated within 60 minutes. The median time to defervescence is 2 to 5 days; therefore, the initial regimen should be continued without alteration for 48 to 72 hours if the patient remains hemodynamically stable. If unexplained fever persists beyond 4 to 7 days despite appropriate antibacterial coverage, the risk of an invasive fungal infection increases substantially, warranting the addition of an empiric antifungal agent.

Step-by-Step Solution

1

Draw peripheral and central venous blood cultures.

Pathogens present in the bloodstream are captured before exposure to antibiotics.

Maximizes the diagnostic yield, allowing for subsequent targeted antimicrobial de-escalation.

2

Administer broad-spectrum antipseudomonal antibiotics.

Immediate coverage against life-threatening bacterial pathogens (e.g., Pseudomonas aeruginosa) is provided.

Neutropenic patients lack the immune cells required to localize infections, making rapid empiric coverage essential.

3

Monitor the patient for 48 to 72 hours without altering the antibiotic regimen.

Adequate time is given for the initial antibiotics to take effect.

The median time to defervescence in neutropenic fever is 2 to 5 days; premature escalation in a stable patient is unwarranted.

4

Initiate empiric antifungal therapy if unexplained fever persists after 4 to 7 days.

Occult invasive fungal infections are treated.

Prolonged neutropenia and broad-spectrum antibiotic use significantly increase the risk for fungal infections (e.g., Candida, Aspergillus).

Key Concept

Algorithmic management of febrile neutropenia

Estimated Time:1m 30s

Internal Medicine

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept